• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:201601006737566465   Update date: Feb. 06, 2025

Shindo Takero

シンドウ タケロウ | Shindo Takero
Clips
Affiliation and department:
Job title: Designated Professor
Research field  (1): Hematology and oncology
Research theme for competitive and other funds  (7):
  • 2023 - 2026 Optimizing immunity in hematopoietic stem cell transplantation focusing on HLA epitopes
  • 2022 - 2025 肝移植後の抗体関連拒絶制御に向けた新規バイオマーカー探索
  • 2021 - 2024 Optimization of immunosuppressive strategy in solid organ transplantation through HLA epitope typing
  • 2021 - 2024 Development of novel biomarkers based on HLA epitopes for organ transplantation and hematopoietic stem cell transplantation
  • 2019 - 2022 Optimizing immunomodulation of hematopoietic stem cell transplantation focusing on allelic polymorphisms of KIRs
Show all
Papers (101):
  • Shigeo Fuji, Masahito Tokunaga, Koji Kato, Nobuaki Nakano, Takero Shindo, Junya Makiyama, Hidehiro Itonaga, Ayumu Ito, Tetsuya Eto, Jun Ishikawa, et al. Significant detrimental impact of pre-transplant mogamulizumab on the post-transplant outcome with a short interval between the last mogamulizumab and transplantation. Bone marrow transplantation. 2025
  • Kosei Nishitani, Satoshi Nakamizo, Takero Shindo, Yo Kaku, Masakazu Fujimoto, Masahiro Hirata, Kai Mizoguchi, Kazuhiro Kawai, Kenji Kabashima. Coexistence of oligoclonal and polyclonal HTLV-1-positive T cells with presentation of acute-type adult T-cell leukaemia-lymphoma successfully treated by ultraviolet B phototherapy and etretinate. Journal of the European Academy of Dermatology and Venereology. 2024
  • Satoko Morishima, Makoto Yoshimitsu, Takero Shindo, Atae Utsunomiya, Takashi Ishida, Ayumu Ito, Nobuaki Nakano, Toshiro Kawakita, Tetsuya Eto, Youko Suehiro, et al. Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphoma. HLA. 2024. 103. 6
  • Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Dai Maruyama, Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, et al. Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results. Haematologica. 2024
  • 枝廣 太郎, 美濃 達治, 樗木 錬, 吉田 徹巳, 杉原 清香, 嬉野 博志, 進藤 岳郎, 一戸 辰夫. 急速な胸水貯留により病勢増悪を認めた多発性骨髄腫の1例. 臨床血液. 2024. 65. 5. 468-469
more...
MISC (24):
  • 岩崎 惇, 諫田 淳也, 田中 秀則, 進藤 岳郎, 土岐 典子, 福田 隆浩, 小澤 幸泰, 衛藤 徹也, 内田 直之, 片山 雄太, et al. HLA class I抗体エピトープは、非血縁者間骨髄移植後における重症急性GVHD発症の増加と関連する. MHC: Major Histocompatibility Complex. 2021. 28. 2Suppl. 85-85
  • Sho Koyasu, Yoichi Shimizu, Mari Suzukida, Takero Shindo, Masahiro Ono, Yuji Nakamoto. Development of a novel radiotracer for imaging T cell lymphoma: In-111-DTPA-Mogamulizumab. JOURNAL OF NUCLEAR MEDICINE. 2021. 62
  • 高柳 俊亮, 山本 伸也, 進藤 岳郎, 柳田 素子. 急性血液浄化が有用であった血管免疫芽球性T細胞リンパ腫(AITL)の二例. 日本透析医学会雑誌. 2020. 53. Suppl.1. 615-615
  • 鈴木田 万里, 志水 陽一, 子安 翔, 進藤 岳郎, 小野 正博, 中本 裕士. CCR4標的治療薬"Mogamulizumab"の生体内分布の解明を目的としたSPECTイメージング剤の開発. 核医学. 2020. 57. Suppl. S152-S152
  • 中野 楓, 中西 加代子, 増田 健太, 西山 有紀子, 長尾 美紀, 進藤 岳郎, 家子 正裕. APTT延長と出血傾向を呈し複数の凝固因子インヒビターを認め、クロスミキシング試験でLAパターンを示した1症例. 日本検査血液学会雑誌. 2020. 21. 学術集会. S223-S223
more...
Lectures and oral presentations  (62):
  • Donor NK cell education by KIR3DL1 and HLA-B associates with reduced relapse in unrelated bone marrow transplantation for adult T-cell leukemia.
    (The 65th Annual Meeting of the American Society of Hematology 2023)
  • 急性型ATLLの病像を呈するもHTLV-1感染細胞はoligoclonalでskin-directed therapyが著効した全身性紅皮症
    (第9回日本HTLV-1学会学術集会 2023)
  • ATLに対する非血縁骨髄移植後の再発はKIR3DL1 educated ドナーで抑制される
    (第9回日本HTLV-1学会学術集会 2023)
  • YY1/EZH2/MLH1はATLの病勢進行のバイオマーカーかつ治療標的となる
    (第9回日本HTLV-1学会学術集会 2023)
  • A new era with newly developed therapeutic reagents against relapsed/resistant ATL
    (2023)
more...
Work history (5):
  • 2023/08 - 現在 Hiroshima University Research Institute for Radiation Biology and Medicine Designated Professor
  • 2016/11 - 2023/07 Kyoto University Hospital Hematology and Oncology Assistant Professor
  • 2012/08 - 2016/10 Saga University Hematology, Respiratory Medicine and Oncology Assistant Professor
  • 2010/08 - 2012/07 University of Miami Sylvester Comprehensive Cancer Center Adult Stem Cell Transplant Program Post-doctoral research fellow
  • 2009/02 - 2010/07 Fred Hutchinson Cancer Research Center Clinical Research Division Post-doctoral research fellow
Awards (11):
  • 2019/03 - 京都大学医学部附属病院 京都大学医学部附属病院病院長賞 パーキンソン病に対するiPS治験支援チームの一員として
  • 2019/02 - 上原記念生命科学財団 一般研究助成
  • 2018 - ノバルティスファーマ株式会社 研究助成
  • 2017/10 - 第26回日本組織適合性学会大会 学術奨励賞(優秀賞)
  • 2017/06 - 小林がん学術振興会 研究助成
Show all
Association Membership(s) (7):
日本血液学会 ,  日本内科学会 ,  日本造血・免疫細胞療法学会 ,  日本癌学会 ,  日本組織適合性学会 ,  日本血液疾患免疫療法学会 ,  日本HTLV-1学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page